INSIGHTS ON CELL & GENE THERAPY DISCOVERY

• Ethical, Considerations As Gene Editing Technologies Advance

  Observe as experts highlight innovative tools and strategies advancing the safety of gene editing therapies while addressing off-target effects, regulatory demands, and manufacturing efficiency.

• How The Pharma Industry Is Closing Health Inequities

  Witness as pharma leaders discuss advancing equity through inclusive trial design, access planning, and global partnerships to overcome persistent health disparities and expand access to lifesaving therapies worldwide.

• Guide To Seeding, Expanding, And Harvesting Stem Cells

  Investigate important considerations for working with three different stem cell types: mesenchymal stem/stromal cells, induced pluripotent stem cells, and neural stem cells.

• What ASCO 2025 Means For The Future Of Oncology Trials

  Review the ASCO 2025 Annual Meeting, highlighting oncology trials and the need for agile, globally capable CRO partners to navigate today’s evolving trial landscape.

• Factors Influencing CD34+ Cell Collection Efficiency In Leukapheresis

  Efficiently collecting sufficient peripheral blood stem cells is paramount for successful transplantation, necessitating a deeper understanding of influencing factors and procedural nuances.

• Broad Biodistribution And Expression Of Allele-Selective LETI-101

  Discover how LETI-101, a novel precision-based CRISPR treatment, can leverage targeted delivery and broad brain distribution to transform Huntington's disease treatment.

• CRISPR Portfolio, Modalities Accelerate Candidate Identification

  See how this cutting-edge, AI-driven genome editing technology can accelerate the development of precise, clinically viable therapies for genetic diseases.

• Peripheral Blood Mononuclear Cell (PBMC) Isolation Using Cell Fractionation Filters

  Discover how this Peripheral Blood Mononuclear Cell (PBMC) isolation method can transform CAR-T manufacturing by reducing costs, accelerating timelines, and improving patient accessibility.

• Signature Of Base Editor RNA Edits And Reduced Exogenous RNA Editing

  Learn how this groundbreaking method for distinguishing base editor-induced RNA edits can enhance the safety and efficacy of genomic medicines.

• Electroporation, LNPs For Targeted CRISPR/Cas9 Gene Editing In T-Cells

  This study compared non-viral transfection methods in primary human T-cells, demonstrating the feasibility of an LNP-based process encapsulating CRISPR/Cas9 and HDR template DNA in a single payload.